Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
New medicines: human
Get the latest updates from New medicines: human directly as they happen.
Follow now 395 followers
Latest posts
Last updated 8 days ago
Human medicines European public assessment report (EPAR): Hetronifly, serplulimab, Status: Opinion
8 days ago
Human medicines European public assessment report (EPAR): Hetronifly, serplulimab, Status: Opinion
Human medicines European public assessment report (EPAR): Pomalidomide Teva, pomalidomide, Status: Opinion
8 days ago
Human medicines European public assessment report (EPAR): Pomalidomide Teva, pomalidomide, Status: Opinion
Human medicines European public assessment report (EPAR): Opuviz, aflibercept, Status: Opinion
8 days ago
Human medicines European public assessment report (EPAR): Opuviz, aflibercept, Status: Opinion
Human medicines European public assessment report (EPAR): Afqlir, aflibercept, Status: Opinion
8 days ago
Human medicines European public assessment report (EPAR): Afqlir, aflibercept, Status: Opinion
Human medicines European public assessment report (EPAR): Theralugand, lutetium (177Lu) chloride, Status: Opinion
8 days ago
Human medicines European public assessment report (EPAR): Theralugand, lutetium (177Lu) chloride, Status...
Human medicines European public assessment report (EPAR): Hympavzi, Marstacimab, Status: Opinion
8 days ago
Human medicines European public assessment report (EPAR): Hympavzi, Marstacimab, Status: Opinion
Human medicines European public assessment report (EPAR): Elahere, mirvetuximab soravtansine, Status: Opinion
8 days ago
Human medicines European public assessment report (EPAR): Elahere, mirvetuximab soravtansine, Status: Opinion
Human medicines European public assessment report (EPAR): Penbraya, Meningococcal group A, B, C, W and Y vaccine, Status: Opinion
8 days ago
Human medicines European public assessment report (EPAR): Penbraya, Meningococcal group A, B...
Human medicines European public assessment report (EPAR): Avzivi, bevacizumab, Date of authorisation: 26/07/2024, Status: Authorised
about 2 months ago
Human medicines European public assessment report (EPAR): Avzivi, bevacizumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Adzynma, rADAMTS13, Date of authorisation: 01/08/2024, Status: Authorised
about 2 months ago
Human medicines European public assessment report (EPAR): Adzynma, rADAMTS13, Date of authorisation...
Human medicines European public assessment report (EPAR): Fymskina, ustekinumab, Status: Opinion
2 months ago
Human medicines European public assessment report (EPAR): Fymskina, ustekinumab, Status: Opinion
Summary of opinion: Mektovi, 25/07/2024 Positive
2 months ago
Summary of opinion: Mektovi, 25/07/2024 Positive